Varicella-Related Deaths among Adults -United States, 1997

Morbidity and Mortality Weekly Report

Volumn 46, Issue 19, 1997, Pages 409-412

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; ANTIVIRUS AGENT; CHICKENPOX VACCINE; VARICELLA ZOSTER IMMUNE GLOBULIN; VARICELLA-ZOSTER IMMUNE GLOBULIN;

ADULT; ARTICLE; CASE REPORT; CHICKENPOX; FEMALE; HUMAN; KIDNEY FAILURE; MORTALITY; MULTIPLE ORGAN FAILURE; PASSIVE IMMUNIZATION; UNITED STATES; VARICELLA ZOSTER VIRUS; VIRUS PNEUMONIA;

ADULT; ANTIVIRAL AGENTS; CHICKENPOX; CHICKENPOX VACCINE; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNE SERA; IMMUNIZATION, PASSIVE; KIDNEY FAILURE; MULTIPLE ORGAN FAILURE; PNEUMONIA, VIRAL; UNITED STATES;

EID: 0031574833     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. CDC. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996;45(no. RR-11).
2. Committee on Infectious Diseases, American Academy of Pediatrics. Recommendations for the use of live attenuated varicella vaccine. Pediatrics 1995;95:791-6.
3. American Academy of Family Physicians. Summary of policy recommendations for periodic health examination. Kansas City, Missouri: American Academy of Family Physicians, November 1996.
4. Gardner P, Eickhoff T, Poland GA, et al. Adult immunizations. Ann Intern Med 1996;124:35-40.
5. Chew D, Hofmann J, O'Donnell C, Finelli L. Physician attitudes and practices regarding varicella vaccine in New Jersey [Abstract]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1996:278.
6. Asano Y, Suga S, Yoshikawa T, et al. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics 1994;94(4 Pt 1):524-6.
7. Kuter BJ, Weibel RE, Guess HA, et al. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991;9:643-7.
8. Wallace MR, Bowler WA, Murray NB, Brodine SK, Oldfield EL III. Treatment of adult varicella with oral acyclovir: a randomized, placebo-controlled trial. Ann Intern Med 1992;117:358-63.
9. Van Loon F, Markowitx L, McQuillan G, et al. Varicella seroprevalence in US population [Abstract]. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1993:359.